May 28, 2025 - 01:21

In a significant move, the founder of Graphjet Technology has increased their stake in the company as it accelerates efforts to finalize its 2024 annual report. This strategic decision comes at a crucial time when the company is under pressure to complete its financial reporting in a timely manner.
The recent changes in board leadership are expected to enhance the company’s focus on its financial obligations, ensuring that the reporting process adheres to regulatory standards. With the new leadership in place, Graphjet Technology is poised to streamline its operations and improve its overall financial transparency.
Investors and stakeholders are closely monitoring the situation, as the timely completion of the annual report is essential for maintaining confidence in the company's performance and future prospects. The founder's increased investment signals a strong belief in the company's direction and potential for growth. As Graphjet Technology works diligently to meet its reporting timeline, the market watches to see how these developments will impact the company's trajectory.
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...